Ionic liquids in pharmaceutical applications

Annual Review of Chemical and Biomolecular Engineering

Volumn 5, Issue , 2014, Pages 527-546

  Marrucho, I M ^a   Branco, L C ^b   Rebelo, L P N ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Drug delivery; Ionic liquids; Pharmaceuticals; Synthesis

Indexed keywords

BIOCHEMISTRY; DRUG DELIVERY; DRUG PRODUCTS; EMISSION CONTROL; SOLAR CELLS; SYNTHESIS (CHEMICAL); CARBON; CARBON CAPTURE; DYE-SENSITIZED SOLAR CELLS; FUEL CELLS; FUEL STORAGE; LIQUIDS;

CARBON CAPTURE AND STORAGE; DOUBLE-LAYER CAPACITORS; DYE-SENSITIZED SOLAR CELL; PHARMACEUTICAL ACTIVE COMPOUNDS; PHARMACEUTICAL APPLICATIONS; PHARMACEUTICAL COMPOUNDS; RESOURCE EFFICIENCIES; SCIENCE AND TECHNOLOGY; DOUBLE LAYER CAPACITOR; ENERGY TECHNOLOGIES; INDUSTRIAL CHALLENGES;

IONIC LIQUIDS;

DRUG; DRUG CARRIER; IONIC LIQUID; SOLVENT;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; METHODOLOGY; PHARMACEUTICALS; PHARMACEUTICS; REVIEW; SOLUBILITY; SYNTHESIS;

DRUG DELIVERY; IONIC LIQUIDS; PHARMACEUTICALS; SYNTHESIS;

DRUG CARRIERS; IONIC LIQUIDS; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SOLVENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84902469923     PISSN: 19475438     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev-chembioeng-060713-040024     Document Type: Review

References (113)

1. Stella VJ. 2010. Prodrugs: some thoughts and current issues. J. Pharm. Sci. 99:4755-65
2. Huttunen KM, Raunio H, Rautio J. 2011. Prodrugs-from serendipity to rational design. Pharmacol. Rev. 63:750-71
3. Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv. Drug Deliv. Rev. 59:603-16
4. Banerjee R, Bhatt PM, Ravindra NV, Desiraju GR. 2005. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities. Cryst. Growth Des. 5:2299-309
5. Berge SM, Bighley LD, Monkhouse DC. 1977. Pharmaceutical salts. J. Pharm. Sci. 66:1-19
6. Childs SL, Chyall LJ, Dunlap JT, Smolenskaya VN, Stahly BC, Stahly GP. 2004. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. J. Am. Chem. Soc. 126:13335-42
7. Dean PM, Turanjanin J, Yoshizawa-Fujita M, MacFarlane DR, Scott JL. 2009. Exploring an anti-crystal engineering approach to the preparation of pharmaceutically active ionic liquids. Cryst. Growth Des. 9:1137-45
8. Elder DP, Holm R, de Diego HL. 2013. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. Int. J. Pharm. 453:88-100
9. Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50:47-60
10. Vasconcelos T, Sarmento B, Costa P. 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 12:1068-75
11. Torchilin VP. 2005. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4:145-60
12. Seddon KR. 1997. Ionic liquids for clean technology. J. Chem. Technol. Biotechnol. 68:351-56
13. Gardas RL, Coutinho JAP. 2009. Group contribution methods for the prediction of thermophysical and transport properties of ionic liquids. AIChE J. 55:1274-90
14. Lopes J, Padua AAH. 2006. Nanostructural organization in ionic liquids. J. Phys. Chem. B 110:3330-35
15. Plechkova NV, Seddon KR. 2008. Applications of ionic liquids in the chemical industry. Chem. Soc. Rev. 37:123-50
16. MacFarlane DR, Tachikawa N, Forsyth M, Pringle JM, Howlett PC, et al. 2014. Energy applications of ionic liquids. Energy Environ. Sci. 7:232-50
17. Zhang X, Zhang X, Dong H, Zhao Z, Zhang S, Huang Y. 2012. Carbon capture with ionic liquids: overview and progress. Energy Environ. Sci. 5:6668-81
18. D'Alessandro DM, Smit B, Long JR. 2010. Carbon dioxide capture: prospects for new materials. Angew. Chem. Int. Ed. 49:6058-82
19. Swatloski RP, Spear SK, Holbrey JD, Rogers RD. 2002. Dissolution of cellose with ionic liquids. J. Am. Chem. Soc. 124:4974-75
20. Larpent JP, Sanglier JJ, eds. 1989. Biotechnologie des Antibiotiques. Paris: Masson
21. Ho TD, Canestraro AJ, Anderson JL. 2011. Ionic liquids in solid-phase microextraction: a review. Anal. Chim. Acta 695:18-43
22. Vidal L, Riekkola ML, Canals A. 2012. Ionic liquid-modified materials for solid-phase extraction and separation: a review. Anal. Chim. Acta 715:19-41
23. Soukup-Hein RJ, Warnke MM, Armstrong DW. 2009. Ionic liquids in analytical chemistry. Annu. Rev. Anal. Chem. 2:145-68
24. Shahriari S,Toḿe LC,Ará ujo JMM, Rebelo LPN, Coutinho JAP, et al. 2013. Aqueous biphasic systems: a benign route using cholinium-based ionic liquids. RSC Adv. 3:1835-43
25. Tang B, Bi W, Tian M, Row KH. 2012. Application of ionic liquid for extraction and separation of bioactive compounds from plants. J. Chromatogr. B 904:1-21
26. HanD, Row KH. 2010. Recent applications of ionic liquids in separation technology. Molecules 15:2405-26
27. Fujita K, MacFarlane DR, Forsyth M. 2005. Protein solubilising and stabilising ionic liquids. Chem. Commun. 38:4804-6
28. van Rantwijk F, Sheldon RA. 2007. Biocatalysis in ionic liquids. Chem. Rev. 107:2757-85
29. Chen XW, Liu JW, Wang JH. 2010. Ionic liquids in the assay of proteins. Anal. Methods 2:1222-26
30. Constatinescu D, Herrmann C,Weingartner H. 2010. Patterns of protein unfolding and protein aggregation in ionic liquids. Phys. Chem. Chem. Phys. 12:1756-63
31. Sheldon RA. 2008. Green and sustainable chemistry: challenges and perspectives. Green Chem. 10:359-60
32. Grodowskai K, Parczewski A. 2010. Organic solvents in the pharmaceutical industry. Acta Pol. Pharm. Drug Res. 67:3-12
33. Bouder F. 2008. Regulating impurities in pharmaceutical products: A tolerability of risk approach Expert Rev. Clin. Pharmacol. 1:241-50
34. Siodmiak T, Piotr Marszall M, Proszowska A. 2012. Ionic liquids: a new strategy in pharmaceutical synthesis. Mini Rev. Org. Chem. 9:203-8
35. Kumar V, Parmar VS, Malhotra SV. 2007. Enhanced solubility and selective benzoylation of nucleosides in novel ionic liquid. Tetrahedron Lett. 48:809-12
36. Kumar V, Malhotra SV. 2008. Synthesis of nucleoside-based antiviral drugs in ionic liquids. Bioorganic Med. Chem. Lett. 18:5640-42
37. Shaabani A, Soleimani E, Maleki A. 2006. Ionic liquid promoted one-pot synthesis of 3-Aminoimidazo[1,2-A]pyridines. Tetrahedron Lett. 47:3031-34
38. Fan XS, Feng D, Qu YY, Zhang XY, Wang JJ, et al. 2010. Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran and their hybridswith nucleoside as potential antiviral and antileishmanial agents. Bioorganic Med. Chem. Lett. 20:809-13
39. Zhang XY, Li XY, LiDF, Qu GR, Wang JJ, et al. 2009. Ionic liquidmediated and promoted eco-friendly preparation of thiazolidinone and pyrimidine nucleoside-thiazolidinone hybrids and their antiparasitic activities. Bioorganic Med. Chem. Lett. 19:6280-83
40. Zaidlewicz M, Cytarska J, Dzielendziak A, Ziegler-BorowskaM. 2004. Synthesis of boronated phenylalanine analogues with a quaternary center for boron neutron capture therapy. Arkivoc 3:11-21
41. Wolan A, Zaidlewicz M. 2003. Synthesis of arylboronates by the palladium catalysed cross-coupling reaction in ionic liquids. Org. Biomol. Chem. 1:3274-76
42. Kurata A, Kitamura Y, Irie S, Takemoto S, Akai Y, et al. 2010. Enzymatic synthesis of caffeic acid phenethyl ester analogues in ionic liquid. J. Biotechnol. 148:133-38
43. Earle MJ, McCormac PB, Seddon KR. 2000. The first high yield green route to a pharmaceutical in a room temperature ionic liquid. Green Chem. 2:261-62
44. Earle MJ, Seddon KR. 2000. Ionic liquids. Green solvents for the future. Pure Appl. Chem. 72:1391-98
45. Monteiro AL, Zinn FK, DeSouza RF, Dupont J. 1997. Asymmetric hydrogenation of 2-Arylacrylic acids catalyzed by immobilizedRu-BINAP complex in 1-n-butyl-3-methylimidazolium tetrafluoroborate molten salt. Tetrahedron Asymmetry 8:177-79
46. Carvalho PO, Cass QB, Calafatti SA, Contesini FJ, Bizaco R. 2006. Review-Alternatives for the separation of drug enantiomers: ibuprofen as a model compound. Braz. J. Chem. Eng. 23:291-300
47. Petkovic M, Ferguson JL, Gunaratne HQN, Ferreira R, Leitao MC, et al. 2010. Novel biocompatible cholinium-based ionic liquids-toxicity and biodegradability. Green Chem. 12:643-49
48. Petkovic M, Seddon KR, Rebelo LPN, Pereira CS. 2011. Ionic liquids: a pathway to environmental acceptability. Chem. Soc. Rev. 40:1383-403
49. Imperato G, K̈ onig B, Chiappe C. 2007. Ionic green solvents from renewable resources. Eur. J. Org. Chem. 7:1049-58
50. Morrissey S, Pegot B, ColemanD,Garcia MT, Ferguson D, et al. 2009. Biodegradable, non-bactericidal oxygen-functionalised imidazolium esters: a step towards 'greener' ionic liquids. Green Chem. 11:475-83
51. Dobler D, Schmidts T, Klingenh ̈ ofer I, Runkel F. 2013. Ionic liquids as ingredients in topical drug delivery systems. Int. J. Pharm. 441:620-27
52. Ranke J,M̈ olter K, Stock F, Bottin-Weber U, Poczobutt J, et al. 2004. Biological effects of imidazolium ionic liquids with varying chain lengths in acute Vibrio fischeri andWST-1 cell viability assays. Ecotoxicol. Environ. Saf. 58:396-404
53. Stepnowski P, Skladanowski AC, Ludwiczak A, Laczynska E. 2004. Evaluating the cytotoxicity of ionic liquids using human cell line HeLa. Hum. Exp. Toxicol. 23:513-17
54. Frade RFM, Afonso CAM. 2010. Impact of ionic liquids in environment and humans: an overview. Hum. Exp. Toxicol. 29:1038-54
55. Coleman D, Gathergood N. 2010. Biodegradation studies of ionic liquids. Chem. Soc. Rev. 39:600-37
56. Jaitely V, Karatas A, Florence AT. 2008. Water-immiscible room temperature ionic liquids (RTILs) as drug reservoirs for controlled release. Int. J. Pharm. 354:168-73
57. Ventura SPM, Gonçalves AMM, Sintra T, Pereira JL, Gonçalves F, Coutinho JAP. 2012. Designing ionic liquids: the chemical structure role in the toxicity. Ecotoxicol. Environ. Saf. 76:162-68
58. Mizuuchi H, JaitelyV,Murdan S, FlorenceAT. 2008.Roomtemperature ionic liquids and their mixtures: potential pharmaceutical solvents. Eur. J. Pharm. Sci. 33:326-31
59. Toḿe LC, Patinha DJS, Freire CSR, Rebelo LPR, Marrucho IM. 2013. CO2 separation applying ionic liquid mixtures: the effect of mixing different anions on gas permeation through supported ionic liquid membranes. RSC Adv. 3:12220-29
60. Forte A, Melo CI, Bogel-Łukasik R, Bogel-Łukasik E. 2012. A favourable solubility of isoniazid, an antitubercular antibiotic drug, in alternative solvents. Fluid Phase Equilib. 318:89-95
61. Lourenço C, Melo CI, Bogel-Łukasik R, Bogel-Łukasik E. 2012. Solubility advantage of pyrazine-2-carboxamide: application of alternative solvents on the way to the future pharmaceutical development. J. Chem. Eng. Data 57:1525-33
62. Manic MS, Najdanovic-Visak V. 2012. Solubility of erythromycin in ionic liquids. J. Chem. Thermodyn. 44:102-6
63. Melo CI, Bogel-Łukasik R, da Ponte MN, Bogel-Łukasik E. 2013. Ammonium ionic liquids as green solvents for drugs. Fluid Phase Equilib. 338:209-16
64. Ranke J, Stolte S, Stormann R, Arning J, Jastorff B. 2007. Design of sustainable chemical products-The example of ionic liquids. Chem. Rev. 107:2183-206
65. Pernak J, Smiglak M, Griffin ST, Hough WL, Wilson TB, et al. 2006. Long alkyl chain quaternary ammonium-based ionic liquids and potential applications. Green Chem. 8:798-806
66. McCrary PD, Beasley PA, Gurau G, Narita A, Barber PS, et al. 2013. Drug specific, tuning of an ionic liquid's hydrophilic-lipophilic balance to improvewater solubility of poorly soluble active pharmaceutical ingredients. New J. Chem. 37:2196-202
67. Jaitely V, Mizuuchi H, Florence AT. 2010. Current-stimulated release of solutes solubilized in waterimmiscible room temperature ionic liquids (RTILs). J. Drug Target. 18:787-93
68. Moniruzzaman M, Tahara Y, Tamura M, Kamiya N, Goto M. 2010. Ionic liquid-Assisted transdermal delivery of sparingly soluble drugs. Chem. Commun. 46:1452-54
69. Moniruzzaman M, Kamiya N, Goto M. 2010. Ionic liquid based microemulsion with pharmaceutically accepted components: formulation and potential applications. J. Colloid Interface Sci. 352:136-42
70. Moniruzzaman M, Tamura M, Tahara Y, Kamiya N, Goto M. 2010. Ionic liquid-in-oil microemulsion as a potential carrier of sparingly soluble drug: characterization and cytotoxicity evaluation. Int. J. Pharm. 400:243-50
71. Gao YN, Han SB, Han BX, Li GZ, Shen D, et al. 2005. TX-100/water/1-butyl- 3-methylimidazolium hexafluorophosphate microemulsions. Langmuir 21:5681-84
72. Zheng YJ, EliWJ, Li G. 2009. FTIR study of Tween80/1-butyl-3- methylimidazolium hexafluorophosphate/toluene microemulsions. Colloid Polym. Sci. 287:871-76
73. Charnay C, Begu S, Tourńe-Ṕeteilh C, Nicole L, Lerner DA, Devoisselle JM. 2004. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. 57:533-40
74. Ńeouze MA, Le Bideau J, Leroux F, Vioux A. 2005. A route to heat resistant solid membranes with performances of liquid electrolytes. Chem. Commun. 2005:1082-84
75. Viau L, Tourńe-Ṕeteilh C, Devoisselle JM, Vioux A. 2010. Ionogels as drug delivery system: one-step sol-gel synthesis using imidazolium ibuprofenate ionic liquid. Chem. Commun. 46:228-30
76. Bica K, Rodŕguez H, Gurau G, Cojocaru OA, Riisager A, et al. 2012. Pharmaceutically active ionic liquids with solids handling, enhanced thermal stability, and fast release. Chem. Commun. 48:5422-24
77. Zhang YY, Chen X, Lan JB, You JS, Chen LJ. 2009. Synthesis and biological applications of imidazoliumbased polymerized ionic liquid as a gene delivery vector. Chem. Biol. Drug Des. 74:282-88
78. Azevedo AMO,RibeiroDMG,Pinto PCAG,Ĺ ucio M, Reis S, SaraivaMLMFS. 2013. Imidazolium ionic liquids as solvents of pharmaceuticals: influence on HSA binding and partition coefficient of nimesulide. Int. J. Pharm. 443:273-78
79. Chuang VTG, Maruyama T, Otagiri M. 2009. Updates on contemporary protein binding techniques. Drug Metab. Pharmacokinet. 24:358-64
80. Rodŕguez H, Bica K, Rogers RD. 2008. Ionic liquid technology: a potential new platform for the pharmaceutical industry. Trop. J. Pharm. Res. 7:1011-12
81. Hickey MB, PetersonML, Manas ES, Alvarez J,Haeffner F, AlmarssonO. 2007. Hydrates and solid-state reactivity: a survey of β-lactam antibiotics. J. Pharm. Sci. 96:1090-99
82. Monissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, et al. 2004. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv. Drug Deliv. Rev. 56:275-300
83. Datta S, Grant DJW. 2004. Crystal structures of drugs: advances in determination, prediction and engineering. Nat. Rev. Drug Discov. 3:42-57
84. Bauer J, Spanton S, Henry R, Quick J, Dziki W, et al. 2001. Ritonavir: an extraordinary example of conformational polymorphism. Pharm. Res. 18:859-66
85. Hulme AT, Price SL, Tocher DA. 2005. A new polymorph of 5-fluorouracil found following computational crystal structure predictions. J. Am. Chem. Soc. 127:1116-17
86. Brodin A, Nyqvistmayer A, Wadsten T, Forslund B, Broberg F. 1984. Phase-diagram and aqueous solubility of lidocaine-prilocaine binary system. J. Pharm. Sci. 73:481-84
87. Stoimenovski J, MacFarlane DR, Bica K, Rogers RD. 2010. Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper. Pharm. Res. 27:521-26
88. ReichertWM,Holbrey JD, Vigour KB,Morgan TD, Broker GA, Rogers RD. 2006. Approaches to crystallization from ionic liquids: complex solvents-complex results, or, a strategy for controlled formation of new supramolecular architectures Chem. Commun. 46:4767-79
89. Golding J, Forsyth S, MacFarlane DR, Forsyth M, Deacon GB. 2002. Methanesulfonate and ptoluenesulfonate salts of the N-methyl-N- Alkylpyrrolidinium and quaternary ammonium cations: novel low cost ionic liquids. Green Chem. 4:223-29
90. Sekhon BS. 2011. Ionic liquids: pharmaceutical and biotechnological applications. Asian J. Pharm. Biol. Res. 1:395-411
91. Stahl PH, Wermuth CG. 2002. Handbook of Pharmaceutical Salts: Properties, Selection, and Use.Weinheim, Ger.:Wiley-VCH
92. Binghley LDBSM, Monkhouse DC. 1966. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker
93. KumarV,Malhotra SV. 2010. Ionic liquids as pharmaceutical salts: a historical perspective. In Ionic Liquid Applications: Pharmaceuticals, Therapeutics, and Biotechnology, ed. SV Malhotra, pp. 1-12. Washington,DC: Am. Chem. Soc.
94. Anderson BD,Conradi RA. 1985. Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J. Pharm. Sci. 74:815-20
95. Carter EB, Culver SL, Fox PA, Goode RD, Ntai I, et al. 2004. Sweet success: ionic liquids derived from non-nutritive sweeteners. Chem. Commun. 6:630-31
96. Higasio YS, Shoji T. 2001. Heterocyclic compounds such as pyrroles, pyridines, pyrollidins, piperdines, indoles, imidazol and pyrazins. Appl. Catal. 221:197-207
97. Clauson-Kaas NKFW. 1955. N-cetyl-3 hydroxypyridinium chloride. US Patent No. 2728775A
98. Baccanar M. 1978. Suppression of cardiac ventricular fibrillation and cardiac arrhythmias with bretylium tosylate. US Patent No. USRE29618E
99. Hoffer M. 1951. Gentisic acid compounds of antipyrines. US Patent No. US2541651A
100. Hough WL, Smiglak M, Rodŕguez H, Swatloski RP, Spear SK, et al. 2007. The third evolution of ionic liquids: active pharmaceutical ingredients. New J. Chem. 31:1429-36
101. Fukumoto K, Yoshizawa M, Ohno H. 2005. Room temperature ionic liquids from 20 natural amino acids. J. Am. Chem. Soc. 127:2398-99
102. Ferraz R, Branco LC, Marrucho IM, Ara ́ ujo JMM, Rebelo LPN, et al. 2012. Development of novel ionic liquids based on ampicillin. Med Chem Comm 3:494-97
103. Florindo C, Ara ́ ujo JMM, Alves F, Matos C, Ferraz R, Prud̂encio C, et al. 2013. Evaluation of solubility and partition properties of ampicillin-based ionic liquids. Int. J. Pharm. 456:553-59
104. Bica K, Rijksen C, Nieuwenhuyzen M, Rogers RD. 2010. In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid. Phys. Chem. Chem. Phys. 12:2011-17
105. Bica K, Rogers RD. 2010. Confused ionic liquid ions-A "liquification" and dosage strategy for pharmaceutically active salts. Chem. Commun. 46:1215-17
106. Hough-Troutman WL, Smiglak M, Griffin S, Reichert WM, Mirska I, et al. 2009. Ionic liquids with dual biological function: sweet and anti-microbial, hydrophobic quaternary ammonium-based salts. New J. Chem. 33:26-33
107. Belieres JP, Angell CA. 2007. Protic ionic liquids: preparation, characterization, and proton free energy level representation. J. Phys. Chem. B 111:4926-37
108. MacFarlane DR, Seddon KR. 2007. Ionic liquids-progress on the fundamental issues. Aust. J. Chem. 60:3-5
109. Nuthakki B, Greaves TL, Krodkiewska I, Weerawardena A, Burgar MI, et al. 2007. Protic ionic liquids and ionicity. Aust. J. Chem. 60:21-28
110. Stoimenovski J, Dean PM, Izgorodina EI, MacFarlane DR. 2012. Protic pharmaceutical ionic liquids and solids: aspects of protonics. Faraday Discuss. 154:335-52
111. O'Neil MJ, ed. 2006. The Merck Index: An Encyclopedia of Chemical, Drugs and Biologicals. Whitehouse Station, NJ: Merck
112. Cole MR, Li M, El-Zahab B, Janes ME, Hayes D, Warner IM. 2011. Design, synthesis, and biological evaluation of β-lactam antibiotic-based imidazolium-And pyridinium-type ionic liquids. Chem. Biol. Drug Des. 78:33-41
113. Alves F, Oliveira FS, Schr ̈ oderB,Matos C, Marrucho IM. 2013. Synthesis, characterization, and liposome partition of a novel tetracycline derivative using the ionic liquids framework. J. Pharm. Sci. 102:1504-12